Abstract
<div>Abstract<p><b>Purpose:</b> Rhabdomyosarcoma (RMS) is a soft tissue sarcoma associated with the skeletal muscle lineage. Of the two predominant subtypes, known as embryonal (eRMS) and alveolar (aRMS), aRMS has the poorer prognosis, with a five-year survival rate of <50%. The majority of aRMS tumors express the fusion protein PAX3–FOXO1. As PAX3–FOXO1 has proven chemically intractable, this study aims to identify targetable proteins that are downstream from or cooperate with PAX3–FOXO1 to support tumorigenesis.</p><p><b>Experimental Design:</b> Microarray analysis of the transcriptomes of human skeletal muscle myoblasts expressing PAX3–FOXO1 revealed alteration of several Wnt pathway gene members, including secreted frizzled related protein 3 (SFRP3), a secreted Wnt pathway inhibitor. Loss-of-function using shRNAs against SFRP3 was used to interrogate the role of SFRP3 in human aRMS cell lines <i>in vitro</i> and conditional murine xenograft systems <i>in vivo</i>. The combination of SFRP3 genetic suppression and the chemotherapeutic agent vincristine was also examined.</p><p><b>Results:</b> <i>In vitro</i>, suppression of SFRP3 inhibited aRMS cell growth, reduced proliferation accompanied by a G<sub>1</sub> arrest and induction of p21, and induced apoptosis. <i>In vivo</i>, doxycycline-inducible suppression of SFRP3 reduced aRMS tumor growth and weight by more than three-fold, in addition to increasing myogenic differentiation and β-catenin signaling. The combination of SFRP3 suppression and vincristine was more effective at reducing aRMS cell growth <i>in vitro</i> than either treatment alone, and ablated tumorigenesis <i>in vivo</i>.</p><p><b>Conclusions:</b> SFRP3 is necessary for the growth of human aRMS cells both <i>in vitro</i> and <i>in vivo</i> and is a promising new target for investigation in aRMS. <i>Clin Cancer Res; 21(21); 4868–80. ©2015 AACR</i>.</p></div>
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
